The Impact of Aging on Multiple Sclerosis

Area of Science:

• Neuroimmunology
• Gerontology
• Demyelinating Diseases

Background:

• Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disorder affecting the central nervous system.
• Age is a critical determinant of MS clinical characteristics and disease phenotype.
• Understanding the aging process in MS is crucial for managing the disease effectively.

Purpose of the Study:

• To review how aging influences the clinical features, pathology, and treatment of multiple sclerosis.
• To explore the role of immunosenescence and innate immunity in chronic MS inflammation.
• To assess optimal treatment strategies for aging individuals with MS.

Main Methods:

• Review of recent studies on aging and MS.
• Characterization of molecular and cellular aspects of chronic active MS lesions.
• Analysis of the impact of immunosenescence on MS pathology and treatment.

Main Results:

• New aging measurement methods enhance understanding of MS aging processes.
• Chronic active MS lesions contribute significantly to disability progression.
• Immunosenescence and innate immunity play vital roles in sustained chronic inflammation in MS.
• MS phenotype is closely linked to chronological age and immunosenescence.

Conclusions:

• Significant progress has been made in understanding the relationship between age and MS.
• This understanding may lead to more targeted and effective treatments for progressive MS.
• Further research is needed to address remaining questions regarding aging and MS management.